Catherine Owen Departs Optinose Board for CEO Role at Acadia
Company Announcements

Catherine Owen Departs Optinose Board for CEO Role at Acadia

Optinose ( (OPTN) ) has issued an announcement.

Catherine Owen has stepped down from the Board of Directors at OptiNose, Inc., leaving amicably without any disputes over the company’s operations, policies, or practices. She is acknowledged for her valuable input during her tenure and is now set to take on the role of Chief Executive Officer at Acadia Pharmaceuticals, Inc.

For a thorough assessment of OPTN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyOptinose price target lowered to $1 from $3 at Piper Sandler
TipRanks Auto-Generated NewsdeskOptinose Shows Prescription Growth Amid Revenue Challenges
TheFlyOptinose reports Q3 EPS 0c, consensus (5c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App